TrialCardiovascular diabetology2022
Effects of treatment with SGLT-2 inhibitors on arginine-related cardiovascular and renal biomarkers.
Arne Gessner et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it